A new treatment for advanced urothelial cancer was effective with tolerable side effects in an international, multi-center phase 2 clinical trial. The trial results prompted a U.S. Food and Drug Administration (FDA) accelerated approval of the treatment on April 13, giving patients with this very aggressive type of cancer a new therapeutic option.
source https://www.sciencedaily.com/releases/2021/08/210802160627.htm
Tuesday, 3 August 2021
Related Posts
New research reveals remarkable resilience of sea life in the aftermath of mass extinctions
Cyclone study improves climate projections
Plant Protector: How plants strengthen their light-harvesting membranes against environmental stress
Western high-fat diet can cause chronic pain, according to new study
Children's beat gestures predict the subsequent development of their oral skills
Harvesting drinking water from humid air around the clock
0 comments: